亚洲金融(00662) - 2024 - 中期业绩

Financial Performance - For the six months ended June 30, 2024, the company reported a profit of HKD 361,387,000, an increase of 20.6% compared to HKD 299,724,000 for the same period in 2023[4] - Total revenue from insurance services was HKD 1,642,356,000, up from HKD 1,244,434,000 in the previous year, reflecting a growth of 32.0%[3] - The company's operating expenses increased to HKD 339,193,000 from HKD 303,700,000, representing an increase of 11.6% year-over-year[4] - The basic and diluted earnings per share rose to HKD 0.389 from HKD 0.321, marking a growth of 21.2%[4] - The total profit before tax for the group was HKD 405,704 for the six months ended June 30, 2024, compared to HKD 338,706 for the same period in 2023, indicating an increase of 19.7%[11] - The group reported a net profit of HKD 299,724 for the six months ended June 30, 2024, compared to HKD 361,387 for the same period in 2023, reflecting a decrease of 17.0%[11] Assets and Liabilities - The total assets of the company as of June 30, 2024, were HKD 14,791,443,000, compared to HKD 15,035,394,000 at the end of 2023, indicating a slight decrease of 1.6%[6] - The total assets of the group as of June 30, 2024, amounted to HKD 14,791,443, up from HKD 13,650,660 as of December 31, 2023, showing a growth of 8.4%[12] - The company's total liabilities decreased slightly to HKD 4,280,651,000 from HKD 4,286,548,000, a reduction of 0.1%[6] - The total liabilities of the group were HKD 4,280,651 as of June 30, 2024, compared to HKD 4,286,548 as of December 31, 2023, indicating a slight decrease of 0.1%[12] - The company has no significant contingent liabilities as of June 30, 2024, indicating a stable financial position[38] Dividends and Share Repurchase - The company declared an interim dividend of HKD 51,038,000, up from HKD 37,220,000, which is an increase of 37.0%[4] - The interim dividend proposed is HKD 0.055 per share, up 37.5% from HKD 0.040 in 2023[18] - The company repurchased and canceled 1,182,000 shares during the reporting period, reducing the total issued shares to 928,114,000[20] - The company repurchased a total of 1,022,000 ordinary shares at a total cost of approximately HKD 3,493,000 during the six months ended June 30, 2024[40] - Following the buyback, the issued share capital of the company was reduced accordingly, resulting in a total of 927,956,000 shares outstanding as of the announcement date[43] Investment Performance - The net profit from investments increased to HKD 108,084,000 from HKD 34,840,000, showing a significant rise of 210.0%[3] - The total realized gains from investments amounted to HKD 22.3 million for the first half of 2024, compared to HKD 4.9 million in the same period last year[15] - The company reported a net unrealized gain on financial assets at fair value through profit or loss of HKD 108.1 million, significantly higher than HKD 34.8 million in the previous year[15] - The investment portfolio generated stable returns in the first half of 2024, benefiting from strong performance across various asset classes, including value stocks and investment-grade fixed income[30] - The strategic investment in Bangkok's Karmel Hospital, which represents 4.7% of the company's holdings, saw its stock price increase by 11.3% in Thai Baht and 3.7% in Hong Kong Dollars during the first half of 2024[31] Operational Developments - The company successfully migrated to a new digital platform in Macau during the first half of the year, reflecting its commitment to improving operational efficiency[28] - The total number of employees increased to 363 as of June 30, 2024, from 352 as of December 31, 2023, reflecting growth in operations[39] - The company is committed to continuous investment in employee training and development, actively recruiting high-quality talent to enhance expertise and diverse perspectives[29] Market Outlook and Strategy - The company remains optimistic about the outlook for the second half of 2024, despite facing complex challenges in the global financial market[22] - The company aims to leverage operational flexibility and a diversified business model to navigate the changing environment[23] - The company plans to increase investment opportunities in developed and developing markets in Asia, such as India, to diversify geopolitical risks and capture high-growth sectors like AI and cybersecurity[26] - The company aims to expand its service offerings in insurance, retirement planning, and healthcare, focusing on Hong Kong, Macau, and mainland China[26] - The global economic growth forecast for 2024 is expected to remain stable at 3.2%, with China projected to grow at 4.6%[24] Compliance and Governance - The company has complied with the Corporate Governance Code, except for a deviation regarding the separation of roles between the Chairman and the CEO[44] - The company’s audit committee reviewed the unaudited condensed consolidated interim financial statements for the six months ended June 30, 2024, and recommended approval by the board[45]